Before we begin today this is one of those posts which we give our permission to share. In fact we wish some of you would post it in its entirety as it will serve as a valuable lesson. Lately we’ve seen a resurgence in this belief that insulin companies aren’t investing in developing newer and better insulins. These complaints come mostly from the same folk who also felt insulin cost too much, correction that the out-of-pocket cost of insulin was too much, and this somehow was the fault of the insulin companies.
Now we know these . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.